Antifibrotic agent, effective in models of pulmonary and lung
fibrosis. Inhibits collagen production and fibroblast proliferation. Regulates
cytokine levels following oral administration in vivo. Potent scavenger of free
radicals and inhibitor of lipid peroxidation.
Kehrer and Margolin (1997) Pirfenidone diminishes
cyclophosphamide-induced lung fibrosis in mice. Toxicol.Lett. 90
125. Iyeret al (1999) Effects of pirfenidone on procollagen gene
expression at the transcriptional level in bleomycin hamster model of lung
fibrosis. J.Pharmacol.Exp.Ther. 289 211. Okuet al
(2002) Pirfenidone suppresses tumor necrosis factor-α, enhances interleukin-10
and protects mice from endotoxic shock. Eur.J.Pharmacol. 446 167.
Meiet al (2006) Protection of pirfenidone against an early phase
of oleic acid-induced acute lung injury in rats. J.Pharmacol.Exp.Ther. 313
379.